295 related articles for article (PubMed ID: 10611107)
1. Effects of proton beam irradiation on uveal melanomas: a comparative study of Ki-67 expression in irradiated versus non-irradiated melanomas.
Chiquet C; Grange JD; Ayzac L; Chauvel P; Patricot LM; Devouassoux-Shisheboran M
Br J Ophthalmol; 2000 Jan; 84(1):98-102. PubMed ID: 10611107
[TBL] [Abstract][Full Text] [Related]
2. Cell proliferation activity in posterior uveal melanoma after Ru-106 brachytherapy: an EORTC ocular oncology group study.
Pe'er J; Stefani FH; Seregard S; Kivela T; Lommatzsch P; Prause JU; Sobottka B; Damato B; Chowers I
Br J Ophthalmol; 2001 Oct; 85(10):1208-12. PubMed ID: 11567966
[TBL] [Abstract][Full Text] [Related]
3. Ki-67 immunostaining in uveal melanoma. The effect of pre-enucleation radiotherapy.
Mooy CM; de Jong PT; Van der Kwast TH; Mulder PG; Jager MJ; Ruiter DJ
Ophthalmology; 1990 Oct; 97(10):1275-80. PubMed ID: 2243677
[TBL] [Abstract][Full Text] [Related]
4. [Correlations of Ki-67 expression and histopathologic characteristics in uveal melanomas].
Liang J; Yi C; Schilling H; Li X
Yan Ke Xue Bao; 2001 Jun; 17(2):114-7, 132. PubMed ID: 12567765
[TBL] [Abstract][Full Text] [Related]
5. Histopathology of proton beam-irradiated vs enucleated uveal melanomas.
Saornil MA; Egan KM; Gragoudas ES; Seddon JM; Walsh SM; Albert DM
Arch Ophthalmol; 1992 Aug; 110(8):1112-8. PubMed ID: 1323252
[TBL] [Abstract][Full Text] [Related]
6. Enucleation after plaque radiotherapy for posterior uveal melanoma. Histopathologic findings.
Shields CL; Shields JA; Karlsson U; Menduke H; Brady LW
Ophthalmology; 1990 Dec; 97(12):1665-70. PubMed ID: 2087297
[TBL] [Abstract][Full Text] [Related]
7. The time course of irradiation changes in proton beam-treated uveal melanomas.
Gragoudas ES; Egan KM; Saornil MA; Walsh SM; Albert DM; Seddon JM
Ophthalmology; 1993 Oct; 100(10):1555-9; discussion 1560. PubMed ID: 8414415
[TBL] [Abstract][Full Text] [Related]
8. A histologic study (including DNA quantification and Ki-67 labeling index) in uveal melanomas after brachytherapy with ruthenium plaques.
Schilling H; Sehu KW; Lee WR
Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):2081-92. PubMed ID: 9331272
[TBL] [Abstract][Full Text] [Related]
9. PC-10 immunostaining of proliferating cell nuclear antigen in posterior uveal melanoma. Enucleation versus enucleation postirradiation groups.
Pe'er J; Gnessin H; Shargal Y; Livni N
Ophthalmology; 1994 Jan; 101(1):56-62. PubMed ID: 7905616
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.
Böker A; Pilger D; Cordini D; Seibel I; Riechardt AI; Joussen AM; Bechrakis NE
Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1767-1775. PubMed ID: 29907945
[TBL] [Abstract][Full Text] [Related]
11. Infiltrating macrophages in extratumoural tissues after brachytherapy of uveal melanoma.
Toivonen P; Kivelä T
Acta Ophthalmol; 2012 Jun; 90(4):341-9. PubMed ID: 20809904
[TBL] [Abstract][Full Text] [Related]
12. Tumour cell proliferation after failed ruthenium plaque radiotherapy for posterior uveal melanoma.
Seregard S; Lundell G; Lax I; af Trampe E; Kock E
Acta Ophthalmol Scand; 1997 Apr; 75(2):148-54. PubMed ID: 9197561
[TBL] [Abstract][Full Text] [Related]
13. The risk of enucleation after proton beam irradiation of uveal melanoma.
Egan KM; Gragoudas ES; Seddon JM; Glynn RJ; Munzenreider JE; Goitein M; Verhey L; Urie M; Koehler A
Ophthalmology; 1989 Sep; 96(9):1377-82; discussion 1382-3. PubMed ID: 2550868
[TBL] [Abstract][Full Text] [Related]
14. Expression of PCNA and Ki-67 in posterior uveal melanomas in adults.
Proniewska-Skretek E; Dziecioł J; Zalewska R; Mariak Z
Rocz Akad Med Bialymst; 2004; 49 Suppl 1():79-81. PubMed ID: 15638382
[TBL] [Abstract][Full Text] [Related]
15. Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy.
Conway RM; Poothullil AM; Daftari IK; Weinberg V; Chung JE; O'Brien JM
Arch Ophthalmol; 2006 Jun; 124(6):838-43. PubMed ID: 16769837
[TBL] [Abstract][Full Text] [Related]
16. Long-term results of proton beam irradiated uveal melanomas.
Gragoudas ES; Seddon JM; Egan K; Glynn R; Munzenrider J; Austin-Seymour M; Goitein M; Verhey L; Urie M; Koehler A
Ophthalmology; 1987 Apr; 94(4):349-53. PubMed ID: 3035451
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of uveal melanoma with iodine 125 plaques or proton beam therapy: indications and comparison of local recurrence rates].
Desjardins L; Lumbroso L; Levy C; Mazal A; Delacroix S; Rosenwald JC; Dendale R; Plancher C; Asselain B
J Fr Ophtalmol; 2003 Mar; 26(3):269-76. PubMed ID: 12746603
[TBL] [Abstract][Full Text] [Related]
18. Intraocular recurrence of uveal melanoma after proton beam irradiation.
Gragoudas ES; Egan KM; Seddon JM; Walsh SM; Munzenrider JE
Ophthalmology; 1992 May; 99(5):760-6. PubMed ID: 1594223
[TBL] [Abstract][Full Text] [Related]
19. Combined proton beam radiotherapy and transpupillary thermotherapy for large uveal melanomas: a randomized study of 151 patients.
Desjardins L; Lumbroso-Le Rouic L; Levy-Gabriel C; Dendale R; Delacroix S; Nauraye C; Estève M; Plancher C; Asselain B
Ophthalmic Res; 2006; 38(5):255-60. PubMed ID: 16888407
[TBL] [Abstract][Full Text] [Related]
20. Histopathologic study of eyes after iodine I 125 episcleral plaque irradiation for uveal melanoma.
Saornil MA; Fisher MR; Campbell RJ; Robertson DM; Earle JD; Eagle RC; Shields JA; Shields CL; Chandra SR; Albert DM
Arch Ophthalmol; 1997 Nov; 115(11):1395-400. PubMed ID: 9366669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
